We are live on ! Find out more
CC

CIBRA Capital Portfolio holdings

AUM $207M
This Fund
S&P 500
This Quarter Est. Return
+18.38%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$293M
AUM Growth
+$146M
Cap. Flow
+$135M
Cap. Flow %
46.23%
Top 10 Hldgs %
84.8%
Holding
38
New
14
Increased
6
Reduced
3
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 32.94%
2 Consumer Staples 12.67%
3 Consumer Discretionary 10.69%
4 Materials 10.16%
5 Energy 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACI icon
26
CALL
Albertsons Companies
ACI
$6.01B
-75,000
Closed -$1.47M
CVX icon
27
CALL
Chevron
CVX
$403B
-78,000
Closed -$11.3M
JNPR
28
PUT
DELISTED
Juniper Networks
JNPR
-28,000
Closed -$1.05M
SLB icon
29
SLB Ltd
SLB
$79.9B
-83,452
Closed -$3.2M
X
30
PUT
DELISTED
US Steel
X
-15,000
Closed -$510K
ALTM
31
DELISTED
Arcadium Lithium plc
ALTM
-825,502
Closed -$4.23M
MTTR
32
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
-988,776
Closed -$4.69M
ZUO
33
DELISTED
Zuora, Inc.
ZUO
-209,035
Closed -$2.07M
ROIC
34
DELISTED
Retail Opportunity Investments Corp.
ROIC
-115,818
Closed -$2.01M
SUM
35
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-19,723
Closed -$998K
RVNC
36
DELISTED
Revance Therapeutics, Inc.
RVNC
-1,139,979
Closed -$3.47M
SMAR
37
DELISTED
Smartsheet Inc.
SMAR
-428,039
Closed -$24M
PSTX
38
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-94,495
Closed -$907K

Similar funds

CIBRA Capital's Q1 2025 Portfolio in Review

As of Q1 2025, CIBRA Capital held 38 positions worth $293M, up 99% from $147M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

CIBRA Capital deployed $135M of net new capital in Q1 2025, opening 14 new positions and adding to 6 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 416,218 shares worth $54.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 5.9% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Discover Financial Services, an estimated $2.08M trimmed.

  • CIBRA Capital's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 416,218 shares worth $54.9M.
  • CIBRA Capital added most to Berry Global Group, Inc. in Q1 2025, an estimated $22.4M increase.
  • CIBRA Capital's biggest Q1 2025 reduction was Discover Financial Services, cutting an estimated $2.08M.
  • CIBRA Capital fully exited Smartsheet Inc. in Q1 2025, selling an estimated $24M.
  • CIBRA Capital's ten largest holdings make up 85% of its $293M portfolio in Q1 2025.
  • CIBRA Capital opened 14 new positions and closed 13 in Q1 2025.
  • CIBRA Capital's portfolio value rose 99% quarter-over-quarter to $293M.

Based on CIBRA Capital's 13F filing for Q1 2025, filed 28 Apr 2025.